Making Medicine

High cost out-of-pocket drugs and obstacles to reduce those prices for patients plague the health industry. With patients in mind, organizations are looking to invest and bring drugs directly to market.
Gaurav Gupta and Hugo Beekman, Co-Founders of Ascendant BioCapital, join the show to discuss their organization and how they’re focusing on drugs that truly make a difference for patients.

What we talked about:

The Founding of Ascendant BioCapital
The Medical & Investing Backgrounds of the Founders
Impactful Experiences in the Industry
Testifying Before Congress & Issues with Out-Of-Pocket Costs
Importance of Intellectual Property to Biotech

To hear more interviews like this one, subscribe to the Making Medicine Podcast on Apple Podcasts, Spotify, or your preferred podcast platform.

As it turns out, many perceptions about the pharmaceutical industry are based without all of the facts.


That’s why we’re sitting down to understand the data with Ravi Mehrotra, Thought Leader and former Senior Managing Director of Biotechnology Equity Research at Evercore ISI.


What we talked about:
- Defining WBPI while taking a closer look at the industry
- The reality that winners pay for all the losers
- Risk and profitability
- HR3 legislation
- Wall Street’s position on the drug pricing debate


Check out these resources we mentioned during the podcast:
- HR 3 legislation


As we continue this new journey together, we would love to hear from you, the listener. Email [email protected] or [email protected] what’s top of mind, what story you want to hear, or what you find interesting!


To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.

Intellectual property (IP) rights have been the driving force behind innovation and entrepreneurship. However, IP has more recently been seen in a negative light.


Through the COVID-19 Pandemic, vaccine IP rights have come into question: should IP rights be waived when concerning an essential technology?


Andrei Iancu, Former Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office, joins the podcast to discuss his views and concerns on IP rights:


What we talked about:
- The Benefits of IP
- How Sentiment of IP Has Changed
- Short, Medium, & Long Term Concerns to Waiving IP Rights
- Where Concerns Should Be Focused & How to Improve IP


Check out the resources below for more information:
- Andrei’s LinkedIn
- Our host: John Stanford’s LinkedIn
- www.incubatecoalition.com

To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.

The fight against Antimicrobial Resistance (AMR) is challenging due to financial, ethical, and legislative issues. Combating infectious disease can prove to be a risky financial investment but much less in comparison to the global impact if solutions are not researched.


Alfonso Chang is the Managing Director of Relativity Healthcare Partners; he shares insight into the challenges and how to overcome them:
- Investor Hesitancy

- Higher clinical and ethical implications

- Preference of existing therapies over new ones

- Unintended consequences from lawmakers due to drafted legislative language


Check out the resources below for more information:

- Alfonso’s LinkedIn

- Our host: John Stanford’s LinkedIn


To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.

In 1980, the Bayh-Dole Act was enacted by U.S. Congress, which changed how ownership of an invention is pursued. Almost 40 years later, how has this act fared?

On Episode 1 of Making Medicine, John Stanford, Executive Director of Incubate Coalition, introduces Joseph Allen and Associates to cover:

- How Bayh-Dole came to be, starting with Purdue University

- The original intent of ‘march-in’ rights and how it affects Bayh-Dole

- Who was this act for, and how has it played out 40 years later?

As we begin on this new journey together, we would love to hear from you, the listener. Email [email protected] or [email protected] what’s top of mind, what story you want to hear, or what you find interesting!

To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.

From chance meetings to risky investments, Making Medicine explores the origin stories of life changing medication and how patients, corporations and investment communities benefit from understanding it.

On today’s episode, Kelsey Kohrs, Producer at Sweet Fish Media and John Stanford, Executive Director of Incubate Coalition introduce Making Medicine, a podcast dedicated to sharing life science stories that have led to scientific breakthroughs. These stories will cover:

- What are the different steps of the drug development process?

- How can we sustain future innovation in the life sciences?

-When chance meetings have led to life changing drug innovation

As we begin on this new journey together, we would love to hear from you, the listener. What’s interesting? What do you want to hear more of? Is there a story that you’ve heard of that you’d like our team to dig in to? Email [email protected] or [email protected].

To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.